Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.

NCT02834559 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

326

Enrollment

OTHER

Sponsor class

Conditions

Rhegmatogenous Retinal Detachment
High-risk for Proliferative Vitreoretinopathy (PVR)

Interventions

DRUG: 5-fluorouracil and low molecular weight heparin
DRUG: Placebo

Sponsor

Universitätsklinikum Köln

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]